Standardisation of cardiac troponin I measurement: past and present

References

• Antman EM, Tanasijevic MJ, Thompson B, et al Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 1342–1349.
   PubMed Web of Science ®Google Scholar
• James S, Armstrong P, Califf R, et al Troponin-T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am J Med 2003; 115: 178–184.
   PubMedGoogle Scholar
• Kontos MC, Shah R, Fritz LM, et al Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients. J Am Coll Cardiol 2004; 43: 958–965.
   PubMedGoogle Scholar
• Eggers KI, Jaffe AS, Lind L, et al Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. Clin Chem 2009; 55: 85–92.
   PubMedGoogle Scholar
• Schulz O, Kirpal K, Stein J, et al Importance of low concentrations of cardiac troponins. Clin Chem 2006; 52: 1614–1615.
   PubMedGoogle Scholar
• Wilson SR, Sabatine MS, Braunwald E, et al Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: Observations from the PROTECT-TIMI 30 Trial. Am Heart J 2009; 158: 386–391.
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Morrow DA, de Lemos JA, et al Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 2009; 30: 162–169.
   PubMed Web of Science ®Google Scholar
• Mingels A, Jacobs L, Michielsen E, et al Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009; 55: 101–108.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, White HD on behalf of the Joint SC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 2007; 116: 2634–2653.
   PubMed Web of Science ®Google Scholar
• Apple FS, Jesse RL, Newby LK, et al for the NACB committee members and the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD). National Academy of Clinical Biochemistry and IFCC Committee on Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 2007; 53: 547–551.
   PubMed Web of Science ®Google Scholar
• The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Committee on the Standardization of Markers of Cardiac Damage (C-SMCD). Troponin assay analytical characteristics. Available at: www.ifcc.org/index.asp?cat=Scientific_Activities&scat=SD_Committees&suba=Standardisation_of_Markers_of_Cardiac_Damage_(C-SMCD)&zip=1&dove=1&numero=53 (accessed 4 January 2010).
   Google Scholar
• Panteghini M, Pagani F, Yeo KT, et al Evaluation of imprecision for cardiac troponin assays at low range concentrations. Clin Chem 2004; 50: 327–332.
   PubMed Web of Science ®Google Scholar
• NHS Purchasing and Supply Agency. Report 05085: Nine troponin assays. London: Centre for Evidence-based Purchasing, December 2005. Available at: http://www.pasa.nhs.uk/PASAWeb/NHSprocurement/CEP/CEPproducts/DES+catalogue++Laboratory+medicine.htm#Labmedicine (accessed 27 November 2009).
   Google Scholar
• Tate JR, Ferguson W, Bais R, et al The determination of the 99th centile level for troponin assays in an Australian reference population. Ann Clin Biochem 2008; 45: 275–288.
   PubMed Web of Science ®Google Scholar
• Venge P, Lagerqvist B, Diderholm E, et al Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). Am J Cardiol 2002; 89: 1035–1041.
   PubMed Web of Science ®Google Scholar
• James S, Flodin M, Johnston N, et al The antibody configurations of cardiac troponin I assays may determine their clinical performance. Clin Chem 2006; 52: 832–837.
   PubMed Web of Science ®Google Scholar
• Panteghini M. A critical appraisal of experimental factors influencing the definition of the 99th percentile limit of cardiac troponins. Clin Chem Lab Med 2009; 47: 1179–1182.
   PubMedGoogle Scholar
• Apple FS, Maturen AJ, Mullins RE, et al Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction. Clin Chem 1999; 45: 206–212.
   PubMedGoogle Scholar
• Christenson RH, Duh SH, Apple FS, et al Towards standardization of cardiac troponin I measurements. Part II: Assessing commutability of candidate reference materials and harmonization of cardiac troponin I assays. Clin Chem 2006; 52: 1685–1692.
   PubMed Web of Science ®Google Scholar
• Katrukha A, Bereznikova A, Pettersson K. New approach to standardization of human cardiac troponin I (cTnI). Scand J Clin Lab Invest 1999; 59 (Suppl 230): 124–127.
   Google Scholar
• Tate JR. Troponin revisited 2008: assay performance. Clin Chem Lab Med 2008; 46: 1489–1500.
   PubMed Web of Science ®Google Scholar
• Katrukha AG, Bereznikova AV, Filatov VL, et al Degradation of cardiac troponin I: implication for reliable immunodetection. Clin Chem 1998; 44: 2433–2440.
   PubMed Web of Science ®Google Scholar
• Labugger R, Organ L, Collier C, et al Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 2000; 102: 1221–1226.
   PubMed Web of Science ®Google Scholar
• McDonough JL, Van Eyk JE. Developing the next generation of cardiac markers: Disease induced modifications of troponin I. Prog Cardiovasc Dis 2004; 47: 207–216.
   PubMed Web of Science ®Google Scholar
• Katrukha AG, Bereznikova AV, Esakova TV, et al Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin Chem 1997; 43: 1379–1385.
   PubMed Web of Science ®Google Scholar
• Lippi G, Targher G, Franchini M, et al Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications. Clin Chem Lab Med 2009; 47: 1183–1194.
   PubMed Web of Science ®Google Scholar
• Wu AHB, Feng YJ, Moore R, et al Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem 1998; 44: 1198–1208.
   PubMed Web of Science ®Google Scholar
• Panteghini M. Current concepts in standardization of cardiac marker immunoassays. Clin Chem Lab Med 2004; 42: 3–8.
   PubMed Web of Science ®Google Scholar
• Panteghini M. Selection of antibodies and epitopes for cardiac troponin immunoassays: should we revise our evidence-based beliefs? Clin Chem 2005; 51: 803–804.
   PubMed Web of Science ®Google Scholar
• Panteghini M, Gerhardt W, Apple FS, et al Quality specifications for cardiac troponin assays. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Clin Chem Lab Med 2001; 39: 174–178.
   Google Scholar
• Panteghini M. Standardization of cardiac troponin I measurements: the way forward? Clin Chem 2005; 51: 1594–1597.
   PubMed Web of Science ®Google Scholar
• Eriksson S, Halenius H, Pulkki K, et al Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. Clin Chem 2005; 51: 839–847.
   PubMed Web of Science ®Google Scholar
• Adamczyk M, Brashear RJ, Mattingly PG. Circulating cardiac troponin-I autoantibodies in human plasma and serum. Ann N Y Acad Sci 2009; 1173: 67–74.
   PubMed Web of Science ®Google Scholar
• Panteghini M. Assay-related issues in the measurement of cardiac troponins. Clin Chim Acta 2009; 402: 88–93.
   PubMedGoogle Scholar
• Bunk DM, Welch MJ. Characterization of a new certified reference material for human cardiac troponin I. Clin Chem 2006; 52: 212–219.
   PubMed Web of Science ®Google Scholar
• Tate JR, Heathcote D, Koerbin G, et al The harmonization of cardiac troponin I measurement is independent of sample time collection but is dependent on the source of calibrator. Clin Chim Acta 2002; 324: 13–23.
   PubMedGoogle Scholar
• Vesper HW, Thienpont LM. Traceability in laboratory medicine. Clin Chem 2009; 55: 1067–1075.
   PubMed Web of Science ®Google Scholar
• Thienpont LM, Van Uytfanghe K, De Leenheer AP. Reference measurement systems in clinical chemistry. Clin Chim Acta 2002; 323: 73–87.
   PubMed Web of Science ®Google Scholar
• Panteghini M. Traceability, reference systems and result comparability. Clin Biochem Rev 2007; 28: 97–104.
   PubMedGoogle Scholar
• Panteghini M, Bunk DM, Christenson RH, et al for the IFCC Working Group on Standardization of Troponin I. Standardization of troponin I measurements: an update. Clin Chem Lab Med 2008; 46: 1501–1506.
   PubMed Web of Science ®Google Scholar
• Vesper HW, Miller WG, Myers GL. Reference materials and commutability. Clin Biochem Rev 2007: 28: 139–147.
   PubMedGoogle Scholar
• Bunk DM. Reference materials and reference measurement procedures: An overview from a National Metrology Institute. Clin Biochem Rev 2007: 28: 131–137.
   PubMedGoogle Scholar
• Stenman UH. Immunoassay standardization: Is it possible, who is responsible, who is capable? Clin Chem 2001; 47: 815–820.
   PubMed Web of Science ®Google Scholar
• Noble JE, Wang L, Cerasoli E, et al An international comparability study to determine the sources of uncertainty associated with a fluorescent ELISA. Clin Chem Lab Med 2008; 46: 1033–1045.
   PubMed Web of Science ®Google Scholar
• Panteghini M. Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement. Clin Chem Lab Med 2010; 48: 7–10.
   PubMed Web of Science ®Google Scholar
• National Institute of Standards and Technology (NIST). Certificate of Analysis – Standard Reference Material (SRM) 2921 – Human Cardiac Troponin ComplexGaithersburg, MD: NIST, 2004.
   Google Scholar